SpaceOAR System
510(k) K181465
SpaceOAR System is a medical device (FDA Class II; FDA product code OVB, Hydrogel Spacer) made by Augmenix, Inc., cleared under FDA 510(k) K181465 on 25 Jun 2018, active as of 9 Oct 2026. One FDA recall is linked to it.
Active
Valid until
No expiry
FDA recalls
1 ongoingDocuments
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK181465 | Date25 Jun 2018 | StatusActive |
Official records
- FDA 510(k) database K181465
From the FDA record
- Received by the FDA
- 4 Jun 2018
- FDA decision
- 25 Jun 2018 (Substantially Equivalent)
- FDA review time
- 21 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Recalls
-
- Ongoing Z-1002-2022
Users need to be aware that embolism is a possible adverse event associated with hydrogel misplacements. Updated IFU provides new procedural instructions, warnings and precautions that describe steps to verify correct placement of the hydrogel following implantation, as well as technique recommendations for the proper placement of SpaceOAR and SpaceOAR Vue.
Timeline
- Cleared FDA 510(k) K181465
- Recall initiated FDA recalls Z-1002-2022
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- OVB
- Device class
- Class II
- Regulation
- 21 CFR Part 892.5725
- Advisory committee
- Radiology
- FDA decision
- SESE Substantially Equivalent
Similar devices
Other devices filed under FDA product code OVB (Hydrogel Spacer).